What is "Evidence Summit on Maternal and Neonatal Mortality in Indonesia" ?

Indonesia still faces major challenges in the health sector, including in reducing maternal and neonatal mortality. Based on the Millennium Development Goals (MDGs) data in 2015, every day more than 40 mothers in Indonesia die of childbirth. This record is certainly worrisome, particularly for Indonesia that has been included in the G20 group, which consists of countries with the largest economy in the world. Moreover, efforts to reduce maternal and neonatal mortality have been carried out for a long time.

  • Bleeding
  • Hypertension and Pregnancy
  • Infection
  • Others

in %

Resource: Regular Report of Ministry of Health, 2015

Cause of maternal mortality

More than 40 mothers in Indonesia die every day due to childbirth, even though as many as 80% have had their pregnancies checked and received help from health care professionals during labor. Meanwhile, institutions in many areas in Indonesia have performed different approach and research to reduce maternal and neonatal mortality.

“Evidence Summit gathers various data, such as program implementation, referral system, improvement in healthcare services, including national health insurance program.”

Akmal Taher, Convener Evidence Summit/Member of Commission for Medical Science, AIPI

“Call for evidence is a continuous process; hence we need an active contribution from the stakeholders.”

Sjamsuhidajat, Steering Commitee/Chair of Commission for Medical Science, AIPI

“The evidences are obtained by valid methods. However, it is also necessary to consider the relevance to the local context.”

Irawan Yusuf, Co-Convener Evidence Summit/Member of Commission for Medical Science, AIPI

“Indonesia has a comprehensive policy, but we lack proper implementation at national and hospital level.”

Fransisca Hadi, PEER Health

“Involvement of parents and family continues to be a challenge, as they often disagree to implement Kangaroo Mother Care (KMC) at home, despite what has been taught at the hospital.”

Hadi Pratomo,
Fakultas Kesehatan Masyarakat Universitas Indonesia

“Puskesmas (primary healthcare facility) is better prepared than others in terms of readiness of service.”

Puti Marzoeki, World Bank Indonesia

“We hope we are able to record all evidence and identify every cause of maternal death.”

Mela Hidayat,United Nations Fund for Population Activities

“A total of 2,069 government and private hospitals are listed in national health insurance program (JKN).”

Edie S. Rachmat, Health Policy Plus

“Indonesia strives to have a world-class hospital, so HAPIE is made to determine the difference of Type A Hospital while being accredited by Hospital Accreditation Commission(KARS) or Joint Commission International (JCI).”

Anhari Achadi, Fakultas Kesehatan Masyarakat Universitas Indonesia

“Audit Maternal Perinatal (AMP) should be implemented with ‘no blame, no shame, no name’ principal.”

Rustini Floranita, World Health Organization

“EMAS intervention in several districts spurs valuable improvements in referral system from primary healthcare facilities (Puskesmas) to hospitals, transportation, and readiness for newborn resuscitation.”

Siti Nurul Qomariyah, Jhpiego

“Kartu Indonesia Sehat (healthcare card): with mutual assistance, everybody can be rescued.”

M. Iqbal Annas, BPJS Kesehatan

Latest News and Activities

Collaboration, the Key to Reducing Maternal and Newborn Deaths in Indonesia

Jakarta, March 28, 2018 - At an Evidence Summit to Reduce Maternal and Newborn Mortality, The Indonesian Academy of Sciences (AIPI) recommended the establishment of a National Committee to Accelerate Maternal and Newborn Mortality Ratio Reduction to Minister of Health Nila F. Moeloek. This and other recommendations for reducing maternal and newborn deaths were generated through a literature review, supported by the United States Government through the US Agency for International Development (USAID), of over 7,000 studies and research findings on such deaths in Indonesia. The Evidence Summit, supported by USAID and implemented from June 2016 to March  2018, convened the Government of Indonesia and stakeholders in health education and services to reach consensus on how to reduce the country’s maternal and newborn mortality rates. The Summit is a follow up to the Reducing Maternal and Neonatal Mortality in Indonesia report, published by AIPI and the U.S. National Academy of Science in 2013, also with USAID support. The report discovered a lack of valid data and information on maternal and newborn deaths in Indonesia spanning several decades and identified the major causes of such deaths. The Evidence Summit process has also confirmed that these causes have not changed significantly since the release of the 2013 report. Causes include: unequal access to quality health services; delay in receiving emergency assistance; inadequate knowledge of reproductive health; unintegrated data and health information system; and also regulatory issues, i.e., the Law on Marriage no. 1/1974, which sets the legal minimum age for a woman to marry at 16 years old. AIPI’s recommendation for a National Committee reflects that efforts to reduce maternal and newborn deaths need to involve stakeholders from the government, higher education institution, health services and communities. AIPI also provided recommendations on place of labor and delivery, collaboration from health care providers, community participation and development of knowledge management system. “Maternal and newborn deaths have complex causes, and therefore, the efforts to reduce the numbers require collaboration from various sectors, such as health professionals, government and community,” said the President of AIPI, Prof. Ir. Sangkot Marzuki. Acting Mission Director USAID Indonesia Ryan Washburn said: “The United States Government, through USAID, supports the Government of Indonesia and other health sector partners to accelerate progress in reducing preventable maternal and newborn deaths. We are extremely proud to support this Evidence Summit, which is bringing together the priorities of ending preventable mother and newborn deaths and improving the availability and use of scientific evidence.” The National Committee would serve as a communication forum for researchers, practitioners and policymakers to align research priorities and policy agendas. AIPI is committed to support the committee by continuing to collect, review and disseminate scientific evidence to strengthen priority actions and policy recommendations to reduce preventable maternal and newborn deaths. AIPI will also continue to convene and engage relevant stakeholders to reach consensus on these actions and policies. This is important since a lot has been done to reduce maternal and neonatal mortality rate despite insignificant result. Evaluation on MDGs in 2015 showed that Indonesia is still far behind, with maternal mortality rate 305/100.000 to the target of 102/100.000. On the other hand, neonatal mortality rate is stagnant for almost a decade, 20/1.000 in 2003 to 19/1.000 in 2012.

Various Circles Step In to Reduce Maternal and Neonatal Mortality Rate

Jakarta – Efforts to reduce maternal and neonatal mortality in Indonesia continues to be carried out by various circles in Indonesia. The Evidence Summit team to reduce maternal and neonatal mortality in Indonesia, steered by the Indonesian Academy of Sciences (AIPI), once again held a meeting of stakeholders in maternal and neonatal health on May 18, 2017. (more…)